Dexilant (dexlansoprazole delayed-release capsules)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
ADVERSE REACTIONS
Clinical Trials Experience
Pediatrics (additional section added)
The safety of DEXILANT...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts